Guaifenesin And Dextromethorphan Hbr Tablet, Extended Release
Product Images NDC 71179-011

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Dextromethorphan Hbr (NDC 71179-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vespyr Brands Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1200 mg/60 mg Blister Carton (21 (3 x 7)Tablets))

The text is a description of a cough and expectorant product called Contac. It contains active ingredients such as Dextromethorphan Hydiobromide USP and Guifenesin USP that control coughing, thin and loosen mucus. The product is in extended-release tablets and should not be used by children under 12 years without a doctor's prescription. Additionally, it gives warnings and directions on how to use the product. If you experience persistent headaches, severe coughing, or coughing for more than a day, you should stop using the product and see a doctor. Otherwise, the inactive ingredients in the product include coldal sicon oid, ypromellos, magnesium searae, microcrystalie elose, povcone, pregeatinized sarch (maze). Finally, the manufacture is Vespyr Brands®, and you could reach out to them for more information via the available phone number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.